ALLR News and Press, Allarity Therapeutics Inc. From 12/05/23

2023-12-05 09:55:33 ET DENVER, Colo., Dec. 5, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Allarity Therapeutics Inc (NASDAQ: ALLR), Clearmind Medicine Inc (NASDAQ: CMND), Harbor Custom Development Inc...

2023-12-05 09:17:19 ET More on Allarity Therapeutics Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial information for Allarity Therapeutics For further details see: Allarity stock so...

2023-12-05 08:49:20 ET DENVER, Colo., Dec 5, 2023 ( www.247marketnews.com )- Allarity Therapeutics, Inc. (NASDAQ: ALLR) reported, this morning, hopeful initial results from its ongoing Phase 2 clinical trial evaluating the efficacy of its PARP inhibitor, stenoparib, in women w...

All evaluable participants, with prior PARP inhibitor therapy and chemotherapy, showed significant tumor shrinkage including one complete response Early data follows Phase 2 dose optimization change from once-daily to twice-daily Boston (December 5, 2023) — ...

INVO BioScience Inc. (INVO) is expected to report for Q3 2023 HIVE Blockchain Technologies Ltd (HIVE) is expected to report $-0.13 for Q2 2024 BioNexus Gene Lab Corp (BGLC) is expected to report for Q1 2024 Adhera Therapeutics Inc (ATRX) is expected to report for Q1 2024 Altus Pow...

Allarity Therapeutics Inc. (ALLR) is expected to report for Q3 2023

2023-11-02 17:24:45 ET More on Allarity Therapeutics Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics Financial information for Allarity Therapeutics For further details see: Allarity Therapeu...

2023-10-10 17:13:34 ET More on Allarity Therapeutics Seeking Alpha’s Quant Rating on Allarity Therapeutics Historical earnings data for Allarity Therapeutics For further details see: Allarity files to sell 4.88M shares of common stock for holders

Allarity will present on development of several drug-specific DRP ® companion diagnostics, and participate in a panel discussion with speakers from Merck and Roche BOSTON , October 2, 2023 — Allarity Therapeutics, Inc. (Allarity or...

CAMBRIDGE, MA / ACCESSWIRE / September 14, 2023 / Allarity Therapeutics (NASDAQ:ALLR) is a biotechnology company focused on realizing true personalized cancer care by developing targeted cancer therapies coupled with companion diagnostics. The company's unique approach involves utilizing its p...